Three papers on MDMA are retracted by medical journal, just a day after Lykos’ FDA rejection

Three ar­ti­cles de­tail­ing the mid-stage tri­al re­sults of Lykos Ther­a­peu­tics’ MD­MA-as­sist­ed ther­a­py were re­tract­ed by the med­ical jour­nal that pub­lished them, cit­ing a fail­ure by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.